baber/WOPTO huggingface dataset:
Patent NZ-540368-A (NZ)
Title: Pull tab on tear strip on plastic cover, including break tab feature, and related apparatus and methods
Inventor: LUBURIC FRANO
IPC: B65D55/06
Filed: 2003-04-03
Abstract: A lid assembly including a tearstrip (30) is disclosed. An extendible connection member (55) has a first end connected to a first end of the tearstrip. The connection member and tearstrip are each integrally moulded along the periphery of the lid (36), with the tearstrip forming part of a downwardly-depending skirt at the periphery. A pull ring (32) is also connected to the first end of the tearstrip.
Patent NZ-542284-A (NZ)
Title: Extension lead device in form of two C shaped loops interconnected at ends for transverse and longitudinal resiliency
Inventor: KHOURY EDWARD JOSEPH
Filed: 2003-02-10
Abstract: The device (10) being spring loaded in its nature of construction and choice of material is shaped to form two "C" shaped elements (2), joined together by two smaller "C" shaped elements (9), transversely positioned, allowing a double spring action in transverse directions in order to expand and contract over a male (11) and female (12) cord connector of different sizes and configurations within reason, causing a clamping action in one direction, keeping the male and female connectors together and transversely keeping itself wrapped around the joint. The device is designed to prevent cords becoming disconnected during operation.
Patent NZ-543532-A (NZ)
Title: Integrity testing of isolation means in an uninterruptible power supply
Inventor: GRUNDMANN STEFFEN
IPC: G01R31/28
Filed: 2005-11-10
Abstract: An uninterruptible power supply (UPS) 10 and method for testing the integrity of isolation means 14 used to isolate an auxiliary power source from a main power supply during disruption to the main power supply are disclosed. The method for testing involves establishing a reverse polarity across the isolation means for a test period during normal operation of the UPS. A voltage proportional to the input voltage to the isolation means is monitored and an error signal is output if the monitored voltage remains or rises above a reference level during the test period. The error signal indicates that the isolation means is faulty and the energy storage unit 16 of the UPS may be discharging stored energy back into the mains network 1.
Patent NZ-547550-A (NZ)
Title: New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
Inventor: LECOUVE JEAN-PIERRE
IPC: C07K5/06
Filed: 2004-12-09
Abstract: The disclosure relates to a method for the industrial synthesis of perindopril having formula (I) and the pharmaceutically-acceptable salts thereof.
Patent NZ-556049-A (NZ)
Title: Marine personal locator apparatus
Inventor: NIX ANTHONY RONALD
IPC: H01Q25/00
Filed: 2005-11-22
Abstract: Disclosed is a marine personal locator apparatus that includes one or more transmitter units wirelessly coupled to one or more receiver units. The transmitter units include a microprocessor adapted to effect transmission of a unique tone identifying the transmitter. The receivers include an omnidirectional and a yagi antenna switchable to a tuned RF amplifier, mixed with a frequency doubled crystal oscillator local oscillator signal, filtering, processing to retrieve any unique identifying tone, and signal strength detection and indication means. The transmitters may be worn by sailors and the receiver may be located on a vessel. The receiver is operable to monitor for any signals of a transmitter worn by a sailor fallen overboard using the omnidirectional antenna and sound a siren in the event of reception of such a signal. A sailor operating the receiver can switch to use the yagi antenna and use the signal strength indication means to determine and monitor the direction of an overboard sailor relative to the vessel.
Patent NZ-560839-A (NZ)
Title: Apparatus for separating fouling contaminants from non-condensable gases at the end of a pyrolysis/thermolysis of biomass process
Inventor: RADLEIN DESMOND ST
Filed: 2005-02-16
Abstract: A method of continuously capturing BioOil and its constituents from a gas stream produced in a fast pyrolysis/ thermolysis process, in a usable liquid form so as to produce a non-condensable gas free of fouling contaminates, comprising: (a) separating BioOil and its constituents from a gas stream using hot inertial separation to maintain the BioOil and its sticky and/or thick constituents at a temperature below its point of rapid degradation and above a point at which its viscosity is low enough to avoid inefficient operation of the separation equipment; (b) providing a settling section following said hot inertial separation step in which a gas temperature is low enough to cause droplets in the gas stream to settle out but with a gas temperature high enough so that a viscosity of said droplets remains low enough to avoid inefficient operation of the separation equipment; and (c) condensing vapour in the gas stream.
Patent NZ-561658-A (NZ)
Title: An inflatable component for an alternating pressure mattress
Inventor: TEASDALE BARRY CHARLES
IPC: A61G7/057
Filed: 2006-02-16
Abstract: An inflatable component 4 for an alternating pressure mattress 1 comprises at least two inflatable cells 15, with each cell 15 having at least two opposite edges 24 and at least part of one of the two opposite edges being free. The free edge lies within an outer peripheral edge of the component 4, and comprises a base layer 7 and a top layer 8 joined together along predetermined lines to define the peripheral edges of the inflatable cells 15.
Patent NZ-563979-A (NZ)
Title: Solid compositions and methods for treating middle-of-the night insomnia
Inventor: SINGH NIKHILESH
IPC: A61K9/20
Filed: 2006-05-23
Abstract: Disclosed is the use of zolpidem or a salt thereof for the manufacture of a medicament for use in the treatment of a subject who characteristically awakens from sleep, has difficulty returning to sleep, and wishes to resume sleep for less than 5 hours, and wherein the medicament comprises less than 5 mg of zolpidem or a pharmaceutically acceptable salt thereof.
Patent NZ-573400-A (NZ)
Title: Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same
Inventor: RISTOL DEBART PERE
IPC: A61K38/37
Filed: 2008-12-03
Abstract: Provided is a process for obtaining a concentrate of Von Willebrand Factor or a complex of Von Willebrand Factor of human or recombinant origin, characterised by: a) preparation of a solution of Von Willebrand Factor or a complex of Factor VIII/Von Willebrand which contains VWF in a concentration of up to 12 IU VWF:RCo/ml and a proportion between Von Willebrand Factor/Factor VIII of 0.4 or more, b) nanofiltration of the solution prepared in a) through a filter having a pore size of less than 35 nanometers in the presence of calcium ions at a concentration above about 0.05 mM. Further provided is the use of the concentrate in the manufacture of a medicament to treat haemophilia A or Von WillebrandÆs disease.
Patent NZ-575836-A (NZ)
Title: Improvements in or Relating to Medicament Delivery Systems
Inventor: SUTHERLAND GARTH CAMPBELL
IPC: G16H70/20
Filed: 2009-03-27
Abstract: A system for managing data relating to patient usage of a medicament delivery device includes a supply of medicament, a medicament dispensing means, data gathering means for gathering data relating to patient usage of the medicament delivery device, a data storage means for storing the data, and a communication means for transmitting the data to at least one web service. The at least one web service is able to share the data with at least one computer program.
Patent NZ-575941-A (NZ)
Title: Method and device to make a beverage where addition of water is indicated after the insertion of a beverage cartridge
Inventor: HUANG JIANMING
IPC: A47J31/32
Filed: 2007-09-07
Abstract: A method and apparatus for indicating the need for water to be added in a beverage brewing machine (1) is disclosed. Provision of a beverage precursor liquid may be enabled based on initiating closure of a brew chamber (11) that is arranged to at least partially enclose a beverage cartridge. A lid control mechanism (21) may lock a reservoir lid (51) in a position to block access to a reservoir and release the lid (51) to allow access to the reservoir in response to closure of the brew chamber (11). The reservoir lid (51) may be opened simultaneously and automatically with opening of the brew chamber (11). The reservoir lid (51) may pneumatically seal the reservoir, e.g. to allow the reservoir to be pressurized to force water to the brew chamber (11). Water in the reservoir may be provided to the brew chamber (11) in response to detection that the water has been sufficiently heated, e.g., based on a thermal cut off switch opening that cuts power to a heater.
Patent NZ-582624-A (NZ)
Title: Forehead support for a facial mask
Inventor: THOMAS JONATHAN HUW
IPC: A62B18/08
Filed: 2008-06-17
Abstract: A respiratory mask includes a mask frame 1145, a forehead support 1150 extending from the mask frame and including a forehead member 1160, headgear including a strap 1170 to be connected to the forehead member, and a flexible beam 1190 on the forehead member. The forehead member includes openings 1162 through which the strap can be looped so that a portion of the strap lies between the forehead member and the forehead of the wearer. The flexible beam is of different material to the strap so as to establish, at least in part, the load distribution applied by the strap to the forehead of the user. One or more layers of the strap are arranged to lie between the flexible beam and the forehead of the wearer to provide padding between and preventing contact between the beam and the forehead of the wearer in use.
Patent NZ-588292-A (NZ)
Title: Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock
Inventor: SOBIREY MICHAEL
IPC: A23L33/15
Filed: 2010-09-29
Abstract: Disclosed is the use of a composition comprising choline, palmitate, vitamin C and vitamin E in the manufacture of a medicament for treating or preventing metabolic stress-induced lung injury, wherein the metabolic stress-induced lung injury is at least one of acute lung injury (ALI), acute respiratory distress syndrome (ARDS), or exercise-induced pulmonary hemorrhage (EIPH). A method for increasing physical capacity of mammalian livestock, the method comprising feeding to the mammalian livestock a supplement comprising choline, palmitate, vitamin C and vitamin E.
Patent NZ-590721-A (NZ)
Title: Food tray cover for food tray in holding cabinet with recessed top panel and front and rear walls of differing heights and having extensions
Inventor: JONES DOUGLAS S
IPC: A47J36/34
Filed: 2006-10-17
Abstract: A food tray is disclosed for covering a food tray for use in a food holding cabinet, and has a recessed top wall surrounded by front, rear and side walls. The front wall extends higher than the rear wall and front and rear walls have respective forward and rearward extensions. (62) Divided Out of 567507
Patent NZ-591189-A (NZ)
Title: Refrigeration controller
Inventor: HOWELL DAVID JAMES
IPC: B60H1/00
Filed: 2011-02-16
Abstract: 591189 Disclosed is low-noise a refrigeration control system for a refrigeration unit having a refrigeration cabinet volume capable of being maintained at a temperature below ambient temperature. The refrigeration unit also has a compressor capable of compressing refrigerant, a condenser capable of cooling refrigerant and an external fan or fans capable of circulating air over the condenser, an evaporator capable of cooling the internal refrigeration cabinet volume, an internal fan or fans capable of circulating air over the evaporator, a sensor detecting the refrigeration unit internal cabinet temperature, a sensor capable of detecting the presence of humans at the refrigeration cabinet, and a controller capable of controlling the fans and compressor in response to the sensors and anticipated actuation of the sensors. The controller has means to adjust the target temperature of the refrigeration cabinet volume, and the controller is capable of controlling at least one of the external fans between two or more operating speeds independently of the ON or OFF operating state of the compressor. This allows that, for a given refrigeration cabinet volume target temperature setting, the fan speed selected in the detected or anticipated presence of human traffic is lower than the speed selected in otherwise identical operating conditions in the absence of human traffic.
Patent NZ-594706-A (NZ)
Title: Direct drive rotary wave energy conversion
Inventor: LAMB BRADFORD
IPC: F03B13/20
Filed: 2010-02-22
Abstract: An apparatus and method for converting wave energy using the relative rotational movement between two interconnected float assemblies and the relative rotational movement between each of the float assemblies and a spar which extends from a connection with the float assemblies at the water surface into the water.
Patent NZ-597266-A (NZ)
Title: Visible light absorbers for ophthalmic lens materials
Inventor: LAREDO WALTER R
IPC: A01N29/06
Filed: 2010-07-02
Abstract: Patent No. 597266 Disclosed is an azo compound of formula I, wherein wherein X1, X2, and X3 independently = H, C1-C6 alkyl, C1-C6 alkoxy, phenoxy, or benzyloxy; Y = H, F, Cl, Br, I, or C1 - C6 alkyl; W = nothing or -O-C(=O)-NH-CH2-CH2-; and Z = H, CH3, C2H51, or CH2OH, such as 2-hydroxy-3-((4-methoxyphenyl)diazenyl)-5-ethylbenzyl methacrylate; 2-hydroxy- 5-methyl- 3-((3,4,5-trimethoxy-phenyl)diazenyl)benzyl methacrylate; and 5-chloro-2-hydroxy-3-((4-methoxyphenyl)diazenyl)benzyl methacrylate.
Patent NZ-600274-A (NZ)
Title: Dialysis systems and methods
Inventor: UPDYKE PALMER DAVID
IPC: A61M1/16
Filed: 2008-11-14
Abstract: 600274 This disclosure generally relates to dialysis systems and related methods. In one aspect of the invention, a dialysis system includes a module configured to retain a device (24) configured so that a medical fluid can pass therethrough, and the device is adapted to remove one or more substances from the medical fluid as the medical fluid passes through the device. The module of the system has an infusate system that introduces an infusate solution to the dialysis solution.
Patent NZ-602106-A (NZ)
Title: A process for preparing zofenopril calcium
Inventor: GORE VINAYAK
IPC: A61K31/401
Filed: 2009-02-26
Abstract: 602106 Disclosed is a process for preparing polymorphic form E of zofenopril calcium, comprising the steps of: (a) dissolving a salt of zofenopril (such as a potassium, sodium, lithium, calcium, magnesium or aluminium salt) in a water miscible organic solvent (such as methanol, ethanol, propanol, isopropanol, n-butanol, tetrahydrofuran or dioxane) which is free of added water; (b) mixing the solution obtained in step (a) with an aqueous solution of a calcium salt; and (c) isolating the polymorphic form of zofenopril calcium; wherein polymorphic form E is characterised by an XRPD spectrum comprising at least six of the following 2θ peaks: 4.2, 4.8, 9.6, 17.5, 18.0, 19.3, 19.9, 20.6 and 24.4 +/- 0.2 degrees 2θ; with the proviso that the salt of zofenopril in step (a) is not an amine salt.
Patent NZ-609333-A (NZ)
Title: Portable electric vaporiser
Inventor: JOHN ROYNON
IPC: F17C9/02
Filed: 2013-05-20
Abstract: 609333 Disclosed is an apparatus when used for vaporising one or more volatile components within a solid or liquid fumigant. The apparatus includes a container vessel (2) for receiving and holding a substantially liquefied or substantially solidified fumigant or fumigant mixture and input means (4) for introducing the fumigant or fumigant mixture to the container vessel (2). Heating means (7) are operatively associated with the container vessel (2) to heat the fumigant or fumigant mixture substantially to or above its boiling point. Control means (6) are operatively associated with the heating means (7) and the container vessel (2). Output means (11) expel a substantially volatilised fumigant upon reaching its boiling point.
Patent NZ-610734-A (NZ)
Title: Human antibodies to the glucagon receptor
Inventor: OKAMOTO HARUKA
IPC: C07K16/28
Filed: 2011-11-22
Abstract: Disclosed is an isolated human antibody or antigen-binding fragment thereof that specifically binds human glucagon receptor (hGCGR), wherein the antibody comprises the complementarity determining regions (CDRs) of a heavy chain variable region (HCVR), wherein the HCVR has an amino acid sequence as set forth in SEQ ID NO: 86; or an amino acid sequence that has at least 95% sequence identity to SEQ ID NO: 86; and the CDRs of a light chain variable region (LCVR), wherein the LCVR has an amino acid sequence as set forth in SEQ ID NO: 88; or an amino acid sequence that has at least 95% sequence identity to SEQ ID NO: 88, wherein the sequences are as defined in the specification. Also disclosed is the use of the antibody for use in lowering blood glucose or ketone levels.
Patent NZ-610925-A (NZ)
Title: Treatment of addiction and impulse-control disorders using pde7 inhibitors
Inventor: DEMOPULOS GREGORY A
IPC: A61P25/36
Filed: 2011-11-07
Abstract: Disclosed herein is the use of a phosphodiesterase 7 (PDE7) inhibitory agent in the manufacture of a medicament for treating or reducing the likelihood of an addiction that is an addiction to an addictive substance, wherein a subject is determined to be at risk of developing an addiction and is administered an amount of an inhibitor of the PDE7 inhibitory agent effective for the treatment or reduced likelihood of the addiction, wherein the PDE7 inhibitory agent is a selective PDE7 inhibitor for which the lesser of the IC50 for inhibiting PDE7A activity and the IC50 for inhibiting PDE7B activity is less than one tenth the IC50 that the agent has for inhibiting the activity of all other PDE enzymes from the PDE1-6 and PDE8-11 enzyme families.
Patent NZ-615518-A (NZ)
Title: Fluid container
Inventor: BEST DARRYL JOHN
IPC: F16N3/04
Filed: 2013-09-13
Abstract: Disclosed is a container (1) for storage and delivery of a fluid. The container comprises a receptacle (2) inside which the fluid is stored, a shaped delivery member (3) fitted to the receptacle (2) and a nozzle. The top of the delivery member narrows to a point (4). The nozzle (5)extends from the point (4) of the delivery portion from which fluid inside the container is dispensed. The nozzle (5) is off set relative to a central vertical container axis. The delivery member comprises two projections extending from the point of the delivery member adjacent the nozzle. These projections may be appropriately placed to guide a chain therebetween and ensure fluid is applied to the chain.
Patent NZ-623347-A (NZ)
Title: Novel anti-dr5 antibody
Inventor: YOSHIDA HIROKO
IPC: C12P21/08
Filed: 2011-10-27
Abstract: Disclosed is an antibody characterized in that:, a heavy chain sequence contains a variable region having CDRH1, CDRH2, and CDRH3, and the CDRH1 comprises an amino acid sequence represented by SEQ ID NO: 82 (GYFMN), the CDRH2 comprises either one of the amino acid sequences represented by SEQ ID NOS: 83 and 89 (RFNPYNXDTFYNQKFKG), and the CDRH3 comprises an amino acid sequence represented by SEQ ID NO: 84 (SAYYFDSGGYFDY); and, a light chain sequence contains a variable region having CDRL1, CDRL2, and CDRL3, and the CDRL1 comprises anyone of the amino acid sequences represented by SEQ ID NOS: 79, 85, 86, 87, and 88 (RSSQSLVHSNXNTYLH), the CDRL2 comprises an amino acid sequence represented by SEQ ID NO: 80 (KVSNRFS), and the CDRL3 comprises an amino acid sequence represented by SEQ ID NO: 81 (SQSTHVPWT), or a functional fragment of the antibody., Further disclosed are antibodies which compete for binding with said antibodies or which bind the same epitope thereof.
Patent NZ-625435-A (NZ)
Title: Fused bicyclic oxazolidinone cetp inhibitor
Inventor: SHAO PENGCHENG PATRICK
IPC: C07D498/04
Filed: 2012-10-25
Abstract: Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. An example of the compound is 4-{ 5-[2-{ (1R,5S,7aS)-1-[3,5-bis(trifluoromethyl)phenyl]-3-oxotetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-5-yl} -4-(trifluoromethyl)phenyl]-6-methoxypyridin-3-yl} -3,5-dimethylbenzoic acid.
Patent NZ-629904-A (NZ)
Title: A winding machine and winding cage for a helically wound pipe
Inventor: CENTOFANTI PAUL
IPC: F16L55/18
Filed: 2013-03-22
Abstract: A winding cage, for winding a helically wound pipe from an elongate ribbed strip having at least one rib and having opposed joinable edge portions, is disclosed. The winding cage includes: a plurality of spaced apart strip guide rollers, the strip guide rollers spaced around a longitudinal winding cage axis; a proximal support frame; a distal support frame having, the proximal and distal support frames spaced apart from each other and together supporting the plurality of spaced apart strip guide rollers; a proximal frame bridge, the bridge extending away from the proximal frame and bridging between spaced apart first and second ends of the proximal support frame; and a proximal mount on the bridge and a distal mount on the distal support frame, the proximal and distal mounts for receiving a strip driver assembly, the strip driver assembly for driving the strip into the winding cage. The bridge forms part of a mouth opening into the winding cage. The mouth is for accommodating the strip driver assembly.
Patent NZ-702869-A (NZ)
Title: Self-retaining systems having laser-cut retainers
Inventor: NAIMAGON ALEXANDER
IPC: D02J3/10
Filed: 2011-05-04
Abstract: Self-retaining suture system including a suture thread (502) bearing a plurality of laser-cut tissue retainers (510) are disclosed. A laser system allows the creation of retainers and self-retaining suture systems in configurations which are difficult and/or impossible to achieve using mechanical cutting technology. The plurality of tissue retainers each have an entrance ramp (514) from which a volume of material has been removed from the suture thread adjacent the tip (512) of the retainer the entrance ramp being adapted to promote engagement of tissue by the tissue engagement surface of the retainer. The inner side of each slot is spaced from the outer side of each slot by approximately the same distance of 10μm or less along the slot.
Patent NZ-704752-A (NZ)
Title: Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
Inventor: RABOISSON PIERRE
IPC: C07D309/14
Filed: 2013-08-28
Abstract: Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R1, R2 and R4 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
Patent NZ-709784-A (NZ)
Title: Pap system
Inventor: FORMICA JUSTIN JOHN
IPC: A61M16/00
Filed: 2012-06-21
Abstract: A system for delivery of pressurized air to a patient, comprising a base unit (2501) including a blower to generate a supply of air at positive pressure, a patient interface (2502) adapted to be provided to a patient’s face, a tube (2503) to deliver the supply of air at positive pressure to the patient interface and a controller (2506) structured to monitor and control adjustment of the system so that the patient interface is optimally positioned for the patient for therapy. The controller is structured to selectively modify a shape of the tube in order to move the patient interface and/or selectively modify an amount of force exerted between the patient interface and the patient to achieve satisfactory seal and comfort.